Concepedia

Raymond Evers

RE

Statistics

Publications

77

Citations

8.8K

H-Index

50

Active since

1987

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

The Netherlands Cancer Institute

University of Washington

Oncode Institute

Max Planck Institute for Biology

Raymond Evers is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, life sciences, and molecular biology.

Publications per year

1987–2023

77

Publications

77

The multidrug resistance protein family

Piet Borst, Raymond Evers, Marcel Kool et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1999 · 650 citations

Life Sciences, Molecular Biology, Pharmacology +12

Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA.

Raymond Evers, Marcel Kool, Liesbeth van Deemter et al. · Journal of Clinical Investigation · 1998 · 615 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein

Jan Wijnholds, Raymond Evers, Manuel R. van Leusden et al. · Nature Medicine · 1997 · 438 citations

Medicine, Immunology, Oncology +14

Functional Multidrug Resistance Protein (MRP1) Lacking the N-terminal Transmembrane Domain

Éva Bakos, Raymond Evers, Gergely Szakács et al. · Journal of Biological Chemistry · 1998 · 328 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16

Interactions of the Human Multidrug Resistance Proteins MRP1 and MRP2 with Organic Anions

Éva Bakos, Raymond Evers, Emese Sinkó et al. · Molecular Pharmacology · 2000 · 317 citations

Medicine, Biochemistry, Pharmacology +17

1–5 of 77